SI

Sophia Innovation Capital

North America, Jalisco, Mexico, Zapopan

Description

Corporate Venture Capital arm of Sophia Pharmaceuticals

Investor Profile

Sophia Innovation Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Health Diagnostics, Home Health Care.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Health Diagnostics
  • Home Health Care
  • Medical
  • Medical Device
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sophia Innovation Capital frequently co-invest with?

Stanford University
North America, California, United States, Stanford
Co-Investments: 1
3E Bioventures
Asia, Beijing, China, Beijing
Co-Investments: 1
Graphene Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
AH
North America, Massachusetts, United States, Newton
Co-Investments: 1
PC
North America, Massachusetts, United States, Natick
Co-Investments: 1
BV
North America, California, United States, Palo Alto
Co-Investments: 1
WS Investments
North America, California, United States, Palo Alto
Co-Investments: 1

What are some of recent deals done by Sophia Innovation Capital?

Smartlens

Mountain View, California, United States

Clinical stage, novel technologies for managing Glaucoma

Health CareHealth DiagnosticsHome Health CareMedicalMedical DevicePersonal Health
Series AJul 11, 2023
Amount Raised: $6,100,000